TrialNeuropsychopharmacology reports2025

Efficacy and safety of lemborexant in subjects with insomnia disorder receiving medications for depression or anxiety symptoms.

Andrew Krystal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.